BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Biochemistry - Biophysics - Ophthalmology

aA-Crystallin–Derived Mini-Chaperone Modulates Stability and Function of Cataract Causing aAG98R-Crystallin
Published: Thursday, September 06, 2012
Author: Murugesan Raju et al.

by Murugesan Raju, Puttur Santhoshkumar, K. Krishna Sharma

Background

A substitution mutation in human aA-crystallin (aAG98R) is associated with autosomal dominant cataract. The recombinant mutant aAG98R protein exhibits altered structure, substrate-dependent chaperone activity, impaired oligomer stability and aggregation on prolonged incubation at 37°C. Our previous studies have shown that aA-crystallin–derived mini-chaperone (DFVIFLDVKHFSPEDLTVK) functions like a molecular chaperone by suppressing the aggregation of denaturing proteins. The present study was undertaken to determine the effect of aA-crystallin–derived mini-chaperone on the stability and chaperone activity of aAG98R-crystallin.

Methodology/Principal Findings

Recombinant aAG98R was incubated in presence and absence of mini-chaperone and analyzed by chromatographic and spectrometric methods. Transmission electron microscope was used to examine the effect of mini-chaperone on the aggregation propensity of mutant protein. Mini-chaperone containing photoactive benzoylphenylalanine was used to confirm the interaction of mini-chaperone with aAG98R. The rescuing of chaperone activity in mutanta-crystallin (aAG98R) by mini-chaperone was confirmed by chaperone assays. We found that the addition of the mini-chaperone during incubation of aAG98R protected the mutant crystallin from forming larger aggregates that precipitate with time. The mini-chaperone-stabilized aAG98R displayed chaperone activity comparable to that of wild-type aA-crystallin. The complexes formed between mini-aA–aAG98R complex and ADH were more stable than the complexes formed between aAG98R and ADH. Western-blotting and mass spectrometry confirmed the binding of mini-chaperone to mutant crystallin.

Conclusion/Significance

These results demonstrate that mini-chaperone stabilizes the mutant aA-crystallin and modulates the chaperone activity of aAG98R. These findings aid in our understanding of how to design peptide chaperones that can be used to stabilize mutant aA-crystallins and preserve the chaperone function.

  More...

 

//-->